Wai Wong

503 total citations
5 papers, 365 citations indexed

About

Wai Wong is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Wai Wong has authored 5 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Wai Wong's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Multiple and Secondary Primary Cancers (2 papers). Wai Wong is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Multiple and Secondary Primary Cancers (2 papers). Wai Wong collaborates with scholars based in United States and United Kingdom. Wai Wong's co-authors include Sabina Cosulich, Helen Won, Teresa Klinowska, Neal Rosen, Vanessa Rodrik-Outmezguine, Zhan Yao, Derek Barratt, Chris J. Novotny, Masanori Okaniwa and Elisa de Stanchina and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Wai Wong

4 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wai Wong United States	4	284	71	58	44	43	5	365
Mike Berger United States	2	284 1.0×	53 0.7×	44 0.8×	40 0.9×	45 1.0×	3	344
Saveur-Michel Maira Switzerland	6	323 1.1×	79 1.1×	50 0.9×	51 1.2×	59 1.4×	8	424
Elizabeth Moskatel United States	3	318 1.1×	96 1.4×	57 1.0×	44 1.0×	35 0.8×	4	389
Caroline Farrington United States	8	353 1.2×	111 1.6×	46 0.8×	77 1.8×	20 0.5×	10	447
Gianmarco Motta Italy	9	194 0.7×	127 1.8×	85 1.5×	80 1.8×	38 0.9×	18	395
Vivek Rathi Australia	10	202 0.7×	110 1.5×	142 2.4×	113 2.6×	28 0.7×	20	398
Mara Mazzoni Italy	10	196 0.7×	117 1.6×	59 1.0×	58 1.3×	23 0.5×	14	330
Julien Bollard France	8	241 0.8×	217 3.1×	120 2.1×	60 1.4×	76 1.8×	16	457
Sahar Mazhar United States	8	253 0.9×	73 1.0×	23 0.4×	47 1.1×	15 0.3×	9	322
Ceri M. Wiggins United Kingdom	9	405 1.4×	112 1.6×	25 0.4×	59 1.3×	56 1.3×	12	492

Countries citing papers authored by Wai Wong

Since Specialization

Citations

This map shows the geographic impact of Wai Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai Wong more than expected).

Fields of papers citing papers by Wai Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wai Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai Wong. The network helps show where Wai Wong may publish in the future.

Co-authorship network of co-authors of Wai Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Wai Wong. A scholar is included among the top collaborators of Wai Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wai Wong. Wai Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Danila, Daniel C., Bruce Montgomery, Russell Z. Szmulewitz, et al.. (2016). A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC). Annals of Oncology. 27. vi565–vi565. 11 indexed citations

2.

Rodrik-Outmezguine, Vanessa, Masanori Okaniwa, Zhan Yao, et al.. (2016). Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature. 534(7606). 272–276. 341 indexed citations

3.

Rodrik-Outmezguine, Vanessa, Masanori Okaniwa, Zhan Yao, et al.. (2016). Abstract 2147: Overcoming mTOR resistance mutations with a new generation mTOR inhibitor. Cancer Research. 76(14_Supplement). 2147–2147.

4.

Poultsides, George A., Elliot L. Servais, Leonard B. Saltz, et al.. (2009). Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of Clinical Oncology. 27(15_suppl). CRA4030–CRA4030. 9 indexed citations

5.

Poultsides, George A., Elliot L. Servais, Leonard B. Saltz, et al.. (2009). Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of Clinical Oncology. 27(18S). CRA4030–CRA4030. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact